Long‐term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low‐dose‐rate brachytherapy for localised prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|121|1|38-45

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.121, Iss.1, 2018-01, pp. : 38-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low dose rate prostate brachytherapy in younger men

By  

BJU INTERNATIONAL, Vol. 121, Iss. 1, 2018-01 ,pp. : 2-2

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high‐risk prostate cancer

By  

BJU INTERNATIONAL, Vol. 116, Iss. 1, 2015-07 ,pp. : 50-56

John Wiley & Sons Inc

Access to resources Recommend Favorite

Health-Related Quality of Life after Radical Prostatectomy and Low-Dose-Rate Brachytherapy for Localized Prostate Cancer

By  

Urologia Internationalis, Vol. 82, Iss. 1, 2009-01 ,pp. : 17-23

Karger

Access to resources Recommend Favorite

Combined high-dose rate brachytherapy (HDR-BT) and whole pelvic radiation therapy (WPRT) in node negative, intermediate- to high-risk localised prostate cancer: clinical outcomes and patient behaviours across ethnicities

By  

Journal of Radiotherapy in Practice, Vol. 16, Iss. 2, 2017-05 ,pp. : 141-147

Cambridge University Press

Access to resources Recommend Favorite

Long‐term outcomes for men with high‐risk prostate cancer treated definitively with external‐beam radiotherapy with or without androgen deprivation

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3260-3261

John Wiley & Sons Inc

Access to resources Recommend Favorite